Randomised controlled trial of exercise training during lactation on breast milk composition in breastfeeding people with overweight/obesity: a study protocol for the MILKSHAKE trial

Abstract

Download PDFPDF Protocol Randomised controlled trial of exercise training during lactation on breast milk composition in breastfeeding people with overweight/obesity: a study protocol for the MILKSHAKE trial

http://orcid.org/0000-0003-1024-8088Trine Moholdt1,2, Emily Rose Ashby1, Karina Hammer Tømmerdal1, Maëliss Cynthia Chloé Lemoine1, Rebecca Lyng Holm1, Pål Sætrom3, http://orcid.org/0000-0001-7726-7684Ann-Charlotte Iversen3,4, Anuradha Ravi1, http://orcid.org/0000-0003-2763-6343Melanie Rae Simpson5, http://orcid.org/0000-0003-2157-8824Guro F Giskeødegård5

Correspondence to Dr Trine Moholdt; trine.moholdt@ntnu.no

Abstract

Breast milk from people with overweight/obesity may differ in composition compared with that from normal-weight people. Exercise training can modify breast milk composition in rodent models, with a beneficial impact demonstrated on the offspring’s metabolism, but whether these findings translate to humans is unclear. This trial aims to determine the effect of an exercise intervention on breast milk composition and whether an exercise-induced modification of breast milk impacts the infants’ growth and body composition. Effect of Exercise Training on Breastmilk Composition is a randomised, controlled trial with two parallel groups, one exercise group and one control group, with a 1:1 allocation. We will include a minimum of 62 exclusively breastfeeding participants, 6 weeks postpartum. The exercise intervention lasts 8 weeks and comprises 25 supervised endurance exercise sessions with moderate or high intensity. The primary outcome measure is the change in the relative concentration of the human milk oligosaccharide 3′sialyllactose in breast milk from baseline at 6 weeks postpartum to the end of the intervention period. Secondary outcomes include breast milk concentrations of other metabolites, cytokines, hormones and microRNA, maternal health outcomes, infant growth, infant gut microbiome and infant circulating microRNA. Maternal and infant outcomes will be measured before, during and after the intervention period, with a follow-up of the infants until they are 24 months old.